Prosight Management, LP Bridge Bio Pharma, Inc. Transaction History
Prosight Management, LP
- $281 Million
- Q1 2025
A detailed history of Prosight Management, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 610,000 shares of BBIO stock, worth $25.1 Million. This represents 7.51% of its overall portfolio holdings.
Number of Shares
610,000
Previous 995,000
38.69%
Holding current value
$25.1 Million
Previous $27.3 Million
22.76%
% of portfolio
7.51%
Previous 8.11%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$907 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$792 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$512 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$295 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.1B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...